PD-1 [Biotinylated] : PD-L1 Inhibitor Screening ELISA Kit
€ Preis anfragen
Immune checkpoint pathway is a focal point of today’s cancer research. PD-1 is one of the best characterized checkpoint proteins. The binding between PD-1 and its ligand PD-L1 suppresses T-cell activation and allows cancer cells to escape from body’s immune surveillance. Therefore, the pharmaceutical inhibition of PD-1 or its ligand has been considered a promising strategy by many oncologists.
This kit is developed for screening for inhibitors of human PD-1 binding to human PD-L1.
Human
2-8℃ RT
This kit is developed for screening for inhibitors of human PD-1 binding to human PD-L1.
